chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient 1st dose 26-Mar-2021 2nd dose on 12-Apr-2022; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) (batch number GK52A, expiry date unknown) and (batch number 7P2PS, expiry date unknown) for prophylaxis.   Previously administered products included Shingrix (received first dose on 26th March 2021 from batch number 7S234 and P2J7E).   On 12th April 2022, the patient received the 2nd dose of Shingrix. On an unknown date, the dose was an unknown dose. On 12th April 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 21-Jun-2022 Reporters comment: The reporter denied consent to follow up. Additional Supportive Information: The patient received two doses of Shingrix, 1 year apart which led to lengthening of vaccination schedule.
TWO WEEKS AFTER SECOND PFISER COVID SHOT RECEIVED VERY URGENT CALL FROM  EMERCENCY ROOM STATING MY PLATLETS HAD DROPED BELOW 5. RUSHED TO EMERCENCY, ADMITTED TO HOSPITAL AND STARTED INFUSIONNS STAT. STAYED IN HOSPITAL FOR 3-4 DAYS AND RELEASED TO SEEK FURTHER MEDICAL HELP.
I received a tetanus booster (90715) in the right arm, then received the GARDASIL (90651) shot in the left. I was told the prick wouldn't hurt until after the injection. I felt nothing until a moment later where it felt like I had been punched in the arm. I then got up and went to check out. While waiting to check out, I got very warm and started overheating. I asked if I could have some water, and was immediately sat down. I continued to worsen and feel on the verge of fainting, and was then wheeled in a wheelchair to an open room to lay down. It took me 20 min before I was able to sit up. Throughout the day, I continued to feel clammy and have spells of cold sweats here and there. At the time of the shot, I lost all color in my face and I did not fully regain it until the following morning. This was injection 1/3 for this vaccine progression.
it was rpt by MD pt exposed to house mate who was vax w/varicella virus vax live. subsequently pt exp a rash that resembles chickenpox
Right leg at injection site became hard (size of lemon), redness, itching, and trouble walking.
No reaction during office visit on 3/19/15 - was notified on 3/23/15 - when I returned to work. Dr notified - returned call to mother no answer on Monday 3/23/15 left message to return call mother returned call on Tuesday 3/24/15 - taken to ER night of 3/19/15. Allergic reaction - hives.
pt had gotten dizzy & fainted; mom caught pt & layed down onto the floor; was assisted back to office 515PM; called MD BP 120/84, P60 reg; 530 BP 117/84; took DPH; c/o was h/a;
This spontaneous report was received from a Medical Assistant concerning an unspecified number of patients. The patients' concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with an improperly stored doses of VARIVAX lot number M035687, expiration date 10-AUG-2018 (dose and route were not reported) for prophylaxis, reconstituted with properly stored of sterile diluent (STERILE DILUENT) (dose, route, lot number and expiration date were not reported). The temperatures involved were from 6°F to 14°F for 15 minutes; from 15°F to 46°F  for 9 hours. It was not previous temperature excursion, and a data logger was involved. No adverse effects were reported. Additional information has been requested.
Approx 8 hrs after receiving vaccine, pt developed redness, swelling and warm to touch at site. Also had fatigue and body aches the following day - now improved. Pt in office now.
After the pt. received her second dose of the vaccine, she was then observed for 15 minutes. Some time after the vaccine (within the first two hours) pt. has a nose bleed that took about 10 minutes to get stopped (per facility staff). Pt. had no other symptoms noted.
This is a spontaneous report from a contactable nurse received via a sales representative. A 16-year-old female patient received TRUMENBA in left arm, at single dose and MENACTRA in right arm, both via an unspecified route of administration, on an unspecified date. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced seizure and loss of color, both on an unspecified date, with unknown outcome.
Pt had second dose of vaccine. Moderna. Pt felt tingles in figures, pt felt light headed. Pt was moved to medical room and checked out. Vs taken and stable . Pt felt better after 20 mins. Pt was released to observation area. Checked out.
Rash, redness and swelling of right arm from elbow joint up to shoulder joint. This was noticed by the patient after going home in the evening around 5 pm, but reported the incident next day.
This spontaneous report as received from a medical assistant refers to a 20 year old patient of unknown gender. The patient's drug allergies and patient medical history was not reported. On 10-JUL-2014 the patient was vaccinated with third dose of GARDASIL (dose, frequency and route of administration were not reported) (lot # K005083, expiry date: 04-NOV-2016) and second dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J014584, expiry date: 16-JAN-2016) which were stored improperly. No adverse effects were noted. No product quality complaint was reported for GARDASIL and VAQTA. This case is linked to 1407USA010956, 1407USA012902, 1407USA012903, 1407USA012904, 1407USA012905, 1407USA012906, 1407USA012907, 1407USA012909, 1407USA012910, 1407USA012911, 1407USA012912, 1407USA012913, 1407USA012914, 1407USA012915, 1407USA012916, 1407USA012917, 1407USA012918, 1407USA012919, 1407USA012920, 1407USA012921, 1407USA012922, 1407USA012923, 1407USA012924, 1407USA012925, 1407USA012926, 1407USA012927, 1407USA012928, 1407USA012929, 1407USA012930, 1407USA012931, 1407USA012932, 1407USA012933, 1407USA012934, 1407USA012935, 1407USA012936, 1407USA012937, 1407USA012938, 1407USA012939, 1407USA012940, 1407USA012941, 1407USA012942, 1407USA012943, 1407USA012944, 1407USA012945, 1407USA012946, 1407USA012947, 1407USA012948, 1407USA012949, 1407USA012950, 1407USA012951, 1407USA012952, 1407USA012953, 1407USA012954, 1407USA012955, 1407USA012956, 1407USA012957, 1407USA012958, 1407USA012959, 1407USA012960, 1407USA012961, 1407USA012962, 1407USA012963, 1407USA012964, 1407USA012965, 1407USA012966, 1407USA012967, 1407USA012968, 1407USA012969, 1407USA012970, 1407USA012971, 1407USA012972, 1407USA012973, 1407USA012974, 1407USA012975, 1407USA012976, 1407USA012977, 1407USA012978, 1407USA012979, 1407USA012980, 1407USA012981, 1407USA012982, 1407USA012983, 1407USA012984, 1407USA012985, 1407USA012986, 1407USA012987, 1407USA012988, 1407USA012989, 1407USA012990, 1407USA012991, 1407USA012992, 1407USA012993, 1407USA012994, 1407USA012995, 1407USA012996, 1407USA012997, 1407USA012998, 1407USA012999, 1407USA013000, 1407USA013013 and 1407USA013014 (same reporter link).
Pt called to report reaction to Pfizer vaccine #1 that she received  3/20/21.  Initially she had a mild reaction including pain in her r hand, headache and racing heart.  These symptoms resolved in 24 hrs.  On 4/9/21 she noticed  severe muscle aches involving her back, neck and arms. She says the pain is severe at times, it waxes and wanes.  She has noticed that she feels better if she moves around.  She is concerned about taking the second vaccine, and feels that this muscle pain is vaccine related.  She does have a history of vaccine allergy (tetanus) Pt advised to contact her allergist for advice on taking vaccine #2.
redness to skin, slight rash near injection site, dizziness, given zyrtec 10 mg PO  observed for additional 20 mins
Coughing, vasovagal (prior history). BP 142/81 (pulse 57), 100% O2 sat.
Patient is adolescent/juvenile of age 17 years. Symptoms: none; Signs: none; Time Course: none
ACHING; FEVER; This spontaneous case report (PVX2019-2483) was received from a consumer on 01-Oct-2019. It described a male consumer who experienced "aching" (PT: Pain) and "fever" (PT: Pyrexia), while being on oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer took third dose of oral Vivotif (one dose every other day) on 30-Sep-2019 and experienced aching with high fever of 101.5 degrees. He reported that he had a low fever all day around 100 and felt like his fever was coming back again. He also reported that the aching was more exacerbated at the night and the morning. He stated that this felt like the symptoms of a mild flu. He also reported that aching and fever was ongoing at the time of the report.   The consumer took Aleve (200 mg; every 5 hours) as treatment medication for the events. The consumer also received travel vaccines last week of Hepatitis A, yellow fever, and tetanus.  Action taken with Vivotif with respect to the event was unknown.  The consumer had not recovered from the reported events.  Company's Comment: In this case, it was reported that the consumer had "aching" and "fever" after intake of Vivotif. There seems to be a temporal association between the intake of the vaccine and the events. Hence, the causality of the events with Vivotif is assessed as possible. Also, fever and abdominal pain are labelled as per CCDS.; Sender's Comments: Company's Comment: In this case, it was reported that the consumer had "aching" and "fever" after intake of Vivotif. There seems to be a temporal association between the intake of the vaccine and the events. Hence, the causality of the events with Vivotif is assessed as possible. Also, fever and abdominal pain are labelled as per CCDS.
nov 16 took shot at 10;00 am at 6;00 pm started with chills and fever and nausea 100.4 at 8:00 pm start severe headache lasted 24 hours nausea as well .Today November 18 no nausea ,fever or headaches but muscle pain in lower legs.
Myalgia, Arthralgia, Fever, ErythemaMultiform, Chills, Injection site pain, Fatigue, Swelling at  injection site Narrative:  Other Relevant History:
started w/1 small dot on tummy that later raised like a mosquito or flea bite;proceeded to spread over entire body, including ears & eyes;took none days to clear up;tx w/DPH, baking soda & baths & colloidal oatmeal baths (did not blister)
Administration of expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046821A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine). On 03-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter who worked at a correctional facility was calling to report that a nurse gave the patient an expired Moderna COVID-19 vaccine. The vial was punctured for more than 12 hours and the dose was administered after the 12 hours. It was also reported that it was patient's first dose and the patient did not experience any symptoms.  No Concomitant product use was reported. No treatment information was provided.
diarrhea lasted several days; fatigue; headaches; nausea lasted several days; terrible congestion, upper respiratory related; lost of appetite; lost of taste; This spontaneous case was reported by a consumer and describes the occurrence of UPPER RESPIRATORY TRACT CONGESTION (terrible congestion, upper respiratory related), DECREASED APPETITE (lost of appetite), AGEUSIA (lost of taste), DIARRHOEA (diarrhea lasted several days) and FATIGUE (fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jan-2021, the patient experienced UPPER RESPIRATORY TRACT CONGESTION (terrible congestion, upper respiratory related), DECREASED APPETITE (lost of appetite), DIARRHOEA (diarrhea lasted several days), FATIGUE (fatigue), HEADACHE (headaches) and NAUSEA (nausea lasted several days). In January 2021, the patient experienced AGEUSIA (lost of taste). At the time of the report, UPPER RESPIRATORY TRACT CONGESTION (terrible congestion, upper respiratory related), DECREASED APPETITE (lost of appetite), AGEUSIA (lost of taste), DIARRHOEA (diarrhea lasted several days), FATIGUE (fatigue), HEADACHE (headaches) and NAUSEA (nausea lasted several days) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: negative (Negative) Negative twice.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
No adverse effects reported; Multiple patients were vaccinated with improperly stored VAQTA; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history, as well as concomitant medications, were not reported.  On 26-JUN-2019, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) 25/0.5 (units not provided), lot # R018935, expiration date 05-SEP-2019, for prophylaxis (dose, route, anatomical site and frequency were not reported). The reporter stated that the vaccine had a temperature excursion of 34.2 F for 4 hours and 54 minutes, which was detected by a data logger. The vaccine had no previous temperature excursion and there were no adverse effects reported.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-1907USA001174: US-009507513-1907USA004852: US-009507513-1907USA004853: US-009507513-1907USA004854: US-009507513-1907USA004855: US-009507513-1907USA004856: US-009507513-1907USA004857: US-009507513-1907USA004858: US-009507513-1907USA004859: US-009507513-1907USA004860: US-009507513-1907USA004861: US-009507513-1907USA004862: US-009507513-1907USA004863: US-009507513-1907USA004864: US-009507513-1907USA004865: US-009507513-1907USA004866: US-009507513-1907USA004867: US-009507513-1907USA004868: US-009507513-1907USA004869: US-009507513-1907USA004870: US-009507513-1907USA004871: US-009507513-1907USA004872: US-009507513-1907USA004873: US-009507513-1907USA004874: US-009507513-1907USA004875: US-009507513-1907USA004876: US-009507513-1907USA004877: US-009507513-1907USA004878: US-009507513-1907USA004879: US-009507513-1907USA004880: US-009507513-1907USA004881: US-009507513-1907USA004882: US-009507513-1907USA004883: US-009507513-1907USA004884: US-009507513-1907USA004885: US-009507513-1907USA004886: US-009507513-1907USA004888: US-009507513-1907USA004889: US-009507513-1907USA004890:
30 min. after flu shot, became hypotensive, B/P 80 systolic, lips cyanotic, uncontrollable shaking, blurred vision, resolved in about 1 hr.
Patient received 1st dose on Covid-19 on 10-19-22. Then 2nd dose received on 10-28-22, this vaccine was administered 9 days after the previous dose. So  dose number was listed as zero.  Client received one dose of Covid-19 Pfizer Bivalent on 11-30-22 instead of Covid-19 Pfizer Monovalent.
Pt called health department experiencing rash and itching all over body, no breathing problems at that time.  I instructed him to take Benadryl now and if symptoms worsened or signs of anaphylaxis appears, then to go to Emergency Room.  Later in evening he had mouth and facial swelling so he went to ER where he was given Epinepherine and steroids. He states he is feeling better today (6/11/2013).
Vaccine order placed by Dr. Vaccine and order double checked by Nurse, LVN. Vaccine administered to patients by CMA and patient and mother was given after visit summary at discharge. Once patient had left, upon attempting to enter the  vaccine that was I administered into system I noticed that orders were gone/canceled. Spoke with Dr and informed that I had given patient vaccine as ordered. Called Patients mother on same day and informed that extra dose was given to patient per order. Answered questions and concerns mother had and patient did not have any side effects at the time. Patient's mother verbalized her understanding. Report documented in system. DTAP/IPV (Kinrix) past vaccine given - 10/15/2021 MMRV (Proquad) past vaccine given - 7/30/2021
Itching all over the body/experienced this after getting the first vaccine; This is a spontaneous report from a contactable consumer (Patient) via a Pfizer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), dose 1 via an unspecified route of administration on 06Feb2021 as dose 1 single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced itching all over the body and it became worse after receiving the second dose. On an unspecified date in 2021, the patient received the second dose. She thought that it was not a side effect of the COVID vaccine. Caller was asking about the side effects of the vaccine. The clinical outcome of event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Swollen lymph nodes; two ultrasounds for follow up. Unknown if any additional ultrasounds are needed
No adverse reaction noted.  Guardian notified that patient should not have received  booster.  Instructed  to monitor kid and call for any problems. Supervisor notified of situation.
Pt called with c/o dizziness, anxiety, abdominal cramping, fever of 100.3F. Pt received pfizer 2nd dose covid-19 vaccine on 6/16/21.
After her first shot on May 28, 2021 (lot EW0173), she had soreness, fever for several days, and fatigue that lingered about a week, and patient has not menstruated since receiving the first vaccine nearly 3 months ago.    Additionally, after her second shot (at pharmacy store) on 6/24/21 (lot EW0217) patient had fever and fatigue for two days, followed by vaginal pain, swelling and sores, which were cultured via a urine sample and skin swab in the Emergency Room .  The results of the culture were negative for any virus or bacteria.  The pain and sores resolved in several days, but she is still not menstruating.
expired doses administered to multiple patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired doses administered to multiple patients) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 24-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired doses administered to multiple patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired doses administered to multiple patients) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided. The vial was punctured for more than 12 hours, the vial was initially stored in the refrigerator on 09-May-2022 and vial was first punctured on 23-May-2022 at 8:30 AM and Product administered to patient on 24-may-2022 at 11:00 AM for one patient and 10:00 AM for one patient. The vial was stored in room temperature and did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F was about 27 hours. No treatment details were provided
Itchy red eyes, sores in mouth, aches in joints, irritablity, headaches. Noticed these symptoms starting around about 06:30 pm with headache, red itchy eyes, irritablity.  Later in the evening I experienced the mouth sores and aches in my joints at about 10:00pm. I still have sores in my mouth and headaches that come and go as of today, 9/18/2010.
First Dose: Pfizer (05/04/2021) Second Dose: Moderna (08/13/2021)
Associate reported that she started itching all over. No rash visible to inspection. Took OTC BENADRYL no relief. Associate went to ER (3/4/2019)and lab drawn for Mumps RT-PCR and Measles RT-PCR. Both have come back negative. Associate followed up with PCP(3/5/2019) and was told she had an allergic reaction but unsure to what.
Case number PHEH2016US028338, is an initial spontaneous report received from a pharmacist on 27 Oct 2016. This report refers to a 51-year-old female patient. Medical history was not reported. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (lot number: 1618401, expiry date: Apr 2017) at a dose of 0.5 ml intramuscular on 27 Oct 2016. On the same day of vaccination, the pharmacist gave FLUVIRIN and the site immediately knotted up. The patient bled a little bit and now there was a round bump in the area. The outcome of the event was unknown. Seriousness of the event was not reported. Causality of the events was not reported.
Tested positive after taking the first shot of the vaccine; Tested positive after taking the first shot of the vaccine; This is a spontaneous report from a Pfizer-sponsored program COVAX US Support. A Non contactable male consumer reported that a male patient of an unspecified age  received bnt162b2 (BNT162B2, Covid-19 Vaccine from Pfizer), via an unspecified route of administration on an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient experienced tested positive after taking the first shot of the vaccine on an unspecified date with outcome of unknown. He wanted  to know if he can still take the second dose. He really need to know as he had been scheduled to receive his send dose tomorrow. He really need to know whether to show up or not. The patient underwent lab tests which included sars-cov-2 test: positive on unknown date.    No follow up attempts are possible. Information about Lot/ Batch could not be obtained.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.
MA gave me the vaccine, she did not check to be sure she did hit a vein. As soon as she inserted the needle a sharp pain went down my left arm and up into my shoulder and neck. I told her that I was having pain and she pushed the needle in further and inserted the solution. I let her know that I have never had a reaction to an influenza vaccine before and have never had an injection hurt so bad. It burned and hurt extremely bad. I could barely move my arm. The next day my left shoulder and arm was swollen, I realized it was not just an injection site issue. I was at the medical center with my husband and asked the nurse in the vaccination clinic if she would check my vaccine. She stated that a vein had been ruptured and the vaccine was high on my arm. I had a fever in my arm, swelling and redness down towards my elbow. I had bruising and extreme pain. I had an extreme limitation of mobility in my arm and shoulder. I was having burning and sharp pinch like pain as well as aching, throbbing pain.